What Do We Have against Operations that Lack Mechanistic Gratification?

Ferguson T.B. , Hammill B.G. , Peterson E.D. A decade of change: risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990–1999; a report from the STS national database committee and the Duke Clinical Research Institute. Ann Thorac Surg. 2002; 73: 480–409.

Bridges C.R. , Horvath K. , Nugent B. The Society of Thoracic Surgeons Practice Guidelines Series: transmyocardial laser revascularization. Ann Thorac Surg. 2004; 77: 1484–1502.

Allen K.B. , Dowling R.D. , Fudge T.L. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. New Engl J Med. 1999; 341: 1029–1036.

Frazier O.H. , March R.J. , Horvath K.A. Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. New Engl J Med. 1999; 341: 1021–1028.

Burkhoff D. , Schmidt S. , Schulman S.P. Transmyocardial laser revascularization compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomized trial. Lancet. 1999; 354: 885–890.

Schofield P.M. , Sharples L.D. , Caine N. Transmyocardial laser revascularization in patients with refractory angina: a randomized controlled trial. Lancet. 1999; 353: 519–524.

Aaberge L. , Nordstrand K. , Dragsund M. Transmyocardial revascularization with CO2 laser in patients with refractory angina pectoris. J Am Coll Cardiol. 2000; 35: 1170–1177.

Allen K.B. , Dowling R.D. , Fudge T. Transmyocardial revascularization versus medical management: long-term follow-up of a randomized, multicenter controlled trial. Ann Thorac Surg. 2004; 77: 1228–1234.

Aaberge L. , Rootwelt K. , Blomhoff S. Continued symptomatic improvement three to five years after transmyocardial revascularization with CO2 laser: a late clinical follow-up of the Norwegian randomized trial with transmyocardial revascularization. J Am Coll Cardiol. 2002; 39: 1588–1593.

Horvath K.A. , Aranki S.F. , Cohn L.C. Sustained angina relief 5 years after transmyocardial laser revascularization with a CO2 laser. Circulation 2001; I81–I84.

Weintraub W.S. , Jones E.L. , Craver J.M. , Guyton R.A. Frequency of repeat coronary bypass or coronary angioplasty after coronary artery bypass surgery using saphenous venous grafts. Am J Cardiol. 1994; 73: 103–112.

Graham M.M. , Chambers R.J. , Davies R.F. Angiographic quantification of diffuse coronary artery disease: reliability and prognostic value for bypass operations. J Thorac Cardiovasc Surg. 1999; 118: 618–627.

Osswald B. , Blackstone E. , Tochtermann U. Does the completeness of revascularization affect early survival after coronary artery bypass grafting in elderly patients? Eur J Cardiothorac Surg. 2001; 20: 120–126.

Prendergast B.D. , Campanella C. , Shaw T.R. Influence of the availability of laser transmyocardial revascularization on surgical strategy in patients with advanced coronary disease. Cardiology. 2001; 95: 90–95.

Kleisli T. , Cheng W. , Jacobs M.J. In the current era, complete revascularization improves survival after coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2006; 129: 1283–1291.

DiMauro M. , Iacò A.L. , Contini M. Reoperative coronary artery bypass grafting: analysis of early and late outcomes. Ann Thorac Surg. 2006; 79: 81–87.

Shah P.J. , Gordon I. , Fuller J. Factors affecting saphenous vein graft patency: clinical and angiographic study in 1402 symptomatic patients operated on between 1977 and 1999. J Thorac Cardiovasc Surg. 2003; 126: 1972–1977.

Yun K.L. , Wu Y. , Aharonian V. Randomized trial of endoscopic versus open vein harvest for coronary artery bypass grafting: six-month patency rates. J Thorac Cardiovasc Surg. 2006; 129: 496–503.

Allen K.B. , Dowling R.D. , Schuch D. Transmyocardial laser revascularization combined with coronary artery bypass grafting: a multi-center, blinded prospective, randomized, controlled trial. J Thorac Cardiovasc Surg. 2000; 119: 540–549.

Frazier O.H. , Tuzun E. , Eichstadt H. Transmyocardial laser revascularization as an adjunct to coronary artery bypass grafting: a randomized, multicenter study with 4-year follow-up. Tex Heart Inst J. 2004; 31: 42–50.

Allen K.B. , Dowling R.D. , Schuch D.R. Adjunctive transmyocardial revascularization: five-year follow-up of a prospective, randomized trial. Ann Thorac Surg. 2004; 78: 458–465.

American Heart Association. Heart disease and stroke statistics—2004 update. www.americanheart.org; accessed October 2005.

Benjamin E.J. , Wolf P.A. , D-Agostino R.B. The Framingham heart study. Circulation. 1998; 98: 946–952.

Lin H.J. , Wolf P.A. , Hayes M.K. Stroke severity in atrial fibrillation. Stroke. 1996; 27: 1760–1764.

Benjamin E.J. , DiAgostino R.B. , Wolf P.A. Left atrial size and the risk of stroke and death. The Framingham Study. Circulation. 1995; 92: 835–841.

Cox J.L. , Schuessler R.B. , D'Agostino The surgical treatment of atrial fibrillation: III. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg. 1991; 101: 569–583.

Cox J.L. , Ad N. , Palazzo T. Current status of the Maze procedure for the treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg. 2000; 12: 15–19.

Williams M.R. , Stewart J.R. , Bolling S.F. Surgical treatment of atrial fibrillation using radiofrequency ablation. Ann Thorac Surg. 2001; 71: 1939–1944.

Defrances C.J. , Hall M.J. , Padgomik M.N. Centers for Disease Control: 2003 National Hospital Discharge Survey. cdc.gov; accessed October 2005.

Quader M.A. , McCarthy P.M. , Gillinov A.M. Does preoperative atrial fibrillation reduce survival after coronary artery bypass grafting? Ann Thorac Surg. 2004; 77: 1514–1522.